35 / 74
CARDIOVASCULAR JOURNAL OF AFRICA • Volume 30, No 2, March/April 2019
AFRICA
101
anti-retroviral drugs efavirenz, tenofovir and emtricitabine on endotheli-
al cell function: Role of PARP.
Cardiovasc Toxicol
2017;
17
(4): 393–404.
17. Wang X, Chai H, Lin PH, Yao Q, Chen C. Roles and mechanisms of
human immunodeficiency virus protease inhibitor ritonavir and other
anti-human immunodeficiency virus drugs in endothelial dysfunction
of porcine pulmonary arteries and human pulmonary artery endothelial
cells.
Am J Pathol
2009;
174
(3): 771–781.
18. Gupta SK, Shen C, Moe SM, Kamendulis LM, Goldman M, Dubé MP.
Worsening endothelial function with efavirenz compared to protease
inhibitors: A 12-month prospective study.
PLoS One
;
7
(9): e45716.
19. Pisoschi A, Pop A. The role of antioxidants in the chemistry of oxidative
stress: a review.
Eur J Med Chem
2015;
97
: 55–74.
20. Ajuwon OR, Marnewick JL, Davids LM. Rooibos (
Aspalathus linearis
)
and its major flavonoids – potential against oxidative stress-induced
conditions. In:
Basic Principles and Clinical Significance of Oxidative
Stress
2015. Available from:
https://www.intechopen.com/books/basic-principles-and-clinical-significance-of-oxidative-stress/rooibos-aspal-
athus-linearis-and-its-major-flavonoids-potential-against-oxidative-
stress-induced-cond.
21. Villaño D, Pecorari M, Testa MF, Raguzzini A, Stalmach A, Crozier
A,
et al
. Unfermented and fermented rooibos teas (
Aspalathus linearis
)
increase plasma total antioxidant capacity in healthy humans.
Food
Chem
2010;
123
(3): 679–683.
22. Street RA, Prinsloo G. Commercially important medicinal plants of
Zimbabwe: A Review.
J Chem
2013;
2013
(205048): 1–16.
23. Pantsi W, Marnewick J, Esterhuyse AJ, Rautenbach F, van Rooyen J.
Rooibos (
Aspalathus linearis
) offers cardiac protection against ischae-
mia/reperfusion in the isolated perfused rat heart.
Phytomedicine
2011;
18
(14): 1220–1228.
24. Dludla P, Muller C, Louw J, Joubert E, Salie R, Opoku AR,
et al.
The
cardioprotective effect of an aqueous extract of fermented rooibos
(
Aspalathus linearis
) on cultured cardiomyocytes derived from diabetic
rats.
Phytomedicine
2014;
21
(5): 595–601.
25. Nakano M, Itoh Y, Mizuno T, Nakashima H. Polysaccharide from
Aspalathus linearis
with strong anti-HIV activity.
Biosci Biotechnol
Biochem
1997;
61
(2): 267–271.
26. Nakano M, Nakashima H, Itoh Y. Anti-human immunodeficiency
virus activity of oligosaccharides from rooibos tea (
Aspalathus linearis
)
extracts
in vitro. Leukemia
1997;
11
( Suppl 3): 128–130.
27. Nair A, Jacob S. A simple practice guide for dose conversion between
animals and human.
J Basic Clin Pharm
2016;
7
(2): 27–31.
28. Marnewick JL, Joubert E, Swart P, van der Westhuizen F, Gelderblom
WC. Modulation of hepatic drug metabolizing enzymes and oxidative
status by rooibos (
Aspalathus linearis
) and honeybush (
Cyclopia interme-
dia
), green and black (
Camellia sinensis
) teas in rats.
J Agric Food Chem
2003;
51
(27): 8113–8119.
29. Beelders T, Sigge GO, Joubert E, De Beer D, de Villiers A. Kinetic
optimisation of the reversed phase liquid chromatographic separation
of rooibos tea (
Aspalathus linearis
) phenolics on conventional high
performance liquid chromatographic instrumentation.
J Chromatogr
2012;
1219
: 128–139.
30. Panz VR1, Raal FJ, Paiker J, Immelman R, Miles H. Performance of the
CardioChek PA and Cholestech LDX point-of-care analysers compared
to clinical diagnostic laboratory methods for the measurement of lipids.
Cardiovasc J Sth Afr
2005;
16
(2): 112–117.
31. Kannengiesser GJ, Opie LH, van der Werff TJ. Impaired cardiac work
and oxygen uptake after reperfusion of regionally ischaemic myocar-
dium.
J Mol Cell Cardiol
1979;
11
(2): 197–207.
32. Westcott C, Genis A, Mthethwa M, Graham R, van Vuuren D,
Huisamen B, Strijdom, H. Fenofibrate protects endothelial cells against
the harmful effects of TNF-alpha.
SA Heart
2017;
14
(1): 22–34.
33. Baba H, Ohtsuka Y, Haruna H, Lee T, Nagata S, Maeda M,
et al.
Studies of anti-inflammatory effects of rooibos tea in rats.
Pediatr Int
2009;
51
(5): 700–704.
34. Ajuwon OR, Oguntibeju OO, Marnewick JL. Amelioration of lipopoly-
saccharide-induced liver injury by aqueous rooibos (
Aspalathus linearis
)
extract via inhibition of pro-inflammatory cytokines and oxidative
stress.
BMC Complement Altern Med
2014;
14
(1): 392.
35. Katengua-Thamahane E, Marnewick JL, Ajuwon OR, Chegou NN,
Sz
ű
cs G, Ferdinandy P,
et al
. The combination of red palm oil and rooi-
bos show anti-inflammatory effects in rats.
J Inflamm
2014;
11
(1): 41.
36. Fadzelly ABM, Asmah R, Fauziah O. Effects of
Strobilanthes crispus
tea aqueous extracts on glucose and lipid profile in normal and
streptozotocin-induced hyperglycemic rats.
Plant Foods Hum Nutr
2006;
61
(1): 6–11.
37. Fisher M, Moyle G, Shahmanesh M, Orkin C, Kingston M, Wilkins
E,
et al
; SWEET (Simplification With Easier Emtricitabine Tenofovir)
group UK. A randomized comparative trial of continued zidovudine/
lamivudine or replacement with tenofovir disoproxil fumarate/emtricit-
abine in efavirenz-treated HIV-1-infected.
J Acquir Immune Defic Syndr
2009;
51
(5): 562–568.
38. Anastos K, Lu D, Shi Q, Tien PC, Kaplan RC, Hessol NA,
et al.
Association of serum lipid levels with HIV serostatus, specific antiret-
roviral agents, and treatment regimens.
J Acquir Immune Defic Syndr
2007;
45
(1): 34–42.
39. Nduka C, Sarki A, Uthman O, Stranges S. Impact of antiretroviral
therapy on serum lipoprotein levels and dyslipidemias: a systematic
review and meta-analysis.
Int J Cardiol
2015;
199
: 307–318.
40. Souza SJ, Luzia LA, Santos SS, Rondó PHC. Lipid profile of
HIV-infected patients in relation to antiretroviral therapy: a review.
Rev
Assoc Med Bras
2013;
59
(2): 186–198.
41. Dave JA, Levitt NS, Ross IL, Lacerda M, Maartens G, Blom D. Anti-
retroviral therapy increases the prevalence of dyslipidemia in South
African HIV-infected patients.
PLoS One
2016;
11
(3): e0151911.
42. Ombeni W, Kamuhabwa AR. Lipid profile in HIV-infected patients
using first-line antiretroviral drugs.
J Int Assoc Provid AIDS Care
2016;
15
(2): 164–171.
43. Da Cunha J. Impact of antiretroviral therapy on lipid metabolism of
human immunodeficiency virus-infected patients: old and new drugs.
World J Virol
2015;
4
(2): 56.
44. Truter D, Chellan N, Strijdom H, Webster I, Rawstorne J, Kotzé SH.
Histomorphological changes in the pancreas and kidney and histo-
pathological changes in the liver in male Wistar rats on antiretroviral
therapy and melatonin.
Acta Histochem
2018;
120
(4): 347–355.
45. Mondal D, Pradhan L, Ali M, Agrawal KC. HAART drugs induce
oxidative stress in human endothelial cells and increase endothe-
lial recruitment of mononuclear cells: Exacerbation by inflammatory
cytokines and amelioration by antioxidants.
Cardiovasc Toxicol
2004;
4
(3): 287–302.
46. Masia M, Padilla S, Bernal E, Almenar M V, Molina J, Hernandez I,
et
al.
Influence of antiretroviral therapy on oxidative stress and cardiovas-
cular risk: a prospective cross-sectional study in HIV-infected patients.
Clin Ther
2007;
29
(7): 1448–1455.
47. Ngondi JL, Oben J, Forkah DM, Etame LH, Mbanya D. The effect
of different combination therapies on oxidative stress markers in HIV
infected patients in Cameroon.
AIDS Res Ther
2006;
3
(19): 1–7.
48. Ibeh BO, Emeka-Nwabunnia IK. Increased oxidative stress condition
found in different stages of HIV disease in patients undergoing antiret-
roviral therapy in Umuahia (Nigeria).
Immunopharmacol Immunotoxicol
2012;
34
(6): 1060–1066.